You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯公吿精選(港股)︱洛陽鉬業(03993.HK)預計2024年度淨利潤增加55.15%-72.12%
格隆匯 01-22 22:36

【今日焦點】

洛陽鉬業(03993.HK)預計2024年度淨利潤增加55.15%-72.12%

洛陽鉬業(03993.HK)公吿,公司預計2024年度實現歸屬於公司股東的淨利潤為人民幣128億元到142億元,與上年同期相比,將增加人民幣45.50億元到59.50億元,同比增加55.15%-72.12%。

預計2024年度實現歸屬於公司股東的扣除非經常性損益的淨利潤為人民幣124億元到138億元,與上年同期相比,將增加人民幣61.67億元到75.67億元,同比增加98.94%-121.40%。

公司2024年業績同比大幅上升的原因系主要產品銅鈷產銷量同比實現大幅增長,疊加銅產品價格同比上升、降本增效等措施效果明顯,使公司實現利潤同比增長。

【重大事項】

華營建築(01582.HK)簽訂一份中標通知書 合約金額約為20億港元

【財報業績】

中國太保(02601.HK)盈喜:預期2024年歸母淨利同比增加約55%到70%

東江環保(00895.HK)預計2024年淨虧損7.85億–7.05億元

哈爾濱電氣(01133.HK)預期2024年度淨利潤約17億元

華潤醫藥(03320.HK):博雅生物2024年淨利潤預計3.8億至4.8億元

亞洲水泥(中國)(00743.HK)盈警:預計年度淨虧損2.637億元

【運營數據】

中國中冶(01618.HK):2024年新籤合同額達12483億元 同比降低12.4%

【醫藥創新】

上海醫藥(02607.HK):熊去氧膽酸膠囊獲得批准生產

聯邦制藥(03933.HK):UBT251注射液慢性腎臟病適應症獲臨牀試驗默示許可

【收購出售】

粵運交通(03399.HK)擬2509.6萬元出售珠海拱運100%股權

中國鑄晨81(00810.HK)出售植華集團(1842.HK)共4110.8萬股股份 套現3918萬港元

【增發供股】

瀛晟科學(00209.HK)擬折讓約19.1%配發940萬股 淨籌120萬港元

【回購註銷】

阿里巴巴-W(09988.HK)1月21日耗資999.6萬美元回購93.6萬股

中遠海控(01919.HK)1月22日耗資1.16億港元回購1008萬股

復星醫藥(02196.HK)擬3億~6億元回購A股 回購價格上限30元/股

友邦保險(01299.HK)1月22日耗資6160萬港元回購112萬股

渣打集團(02888.HK)1月21日耗資590.8萬英鎊回購54.9萬股

快手-W(01024.HK)1月22日耗資3959萬港元回購98萬股

貝殼-W(02423.HK)1月21日耗資500.35萬美元回購87.11萬股

匯豐控股(00005.HK)1月21日耗資2717.7萬港元回購34.48萬股

廣汽集團(02238.HK)1月22日耗資2496.86萬港元回購816萬股

保誠(02378.HK)1月21日耗資170.54萬英鎊回購26萬股

波司登(03998.HK)1月22日耗資1366萬港元回購380萬股

時代電氣(03898.HK)1月22日耗資1277.02萬港元回購43.62萬股

麗珠醫藥(01513.HK)1月22日耗資1175.41萬元回購32.62萬股A股

太古股份公司A(00019.HK)1月22日耗資1000萬港元回購14.6萬股

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account